Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
43.30
-0.26 (-0.60%)
Jan 22, 2026, 1:19 PM EST - Market open
Soleno Therapeutics Employees
Soleno Therapeutics had 152 employees as of September 30, 2025. The number of employees increased by 60 or 65.22% compared to the same quarter last year.
Employees
152
Change
60
Growth
65.22%
Revenue / Employee
$649,178
Profits / Employee
-$516,118
Market Cap
2.33B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 152 | 60 | 65.22% |
| Jun 30, 2025 | 133 | - | - |
| Mar 31, 2025 | 115 | 82 | 248.48% |
| Dec 31, 2024 | 92 | 59 | 178.79% |
| Dec 31, 2023 | 33 | 8 | 32.00% |
| Dec 31, 2022 | 25 | 5 | 25.00% |
| Dec 31, 2021 | 20 | 3 | 17.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 1,372 |
| Ultragenyx Pharmaceutical | 1,294 |
| Recursion Pharmaceuticals | 800 |
| Galapagos NV | 704 |
| Ascentage Pharma Group International | 567 |
| Travere Therapeutics | 385 |
| Wave Life Sciences | 288 |
| Ocular Therapeutix | 274 |
SLNO News
- 17 days ago - Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT™ XR in the Journal of Clinical Endocrinology and Metabolism - GlobeNewsWire
- 5 weeks ago - Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - PRNewsWire
- 7 weeks ago - Soleno Therapeutics Announces the Passing of Board Member William G. Harris - GlobeNewsWire
- 2 months ago - Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% – Hagens Berman - GlobeNewsWire
- 2 months ago - Soleno Therapeutics, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 2 months ago - Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement - GlobeNewsWire
- 2 months ago - Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman - PRNewsWire
- 2 months ago - Soleno Therapeutics, Inc. (SLNO) Q3 2025 Earnings Call Transcript - Seeking Alpha